A targeting construct was designed to replace exons 4-7 of the mitogen-activated protein kinase kinase 7 (Map2k7 or Jnkk2) gene with a loxP-flanked neomycin (neo) resistance cassette. Cre-mediated recombination removed the selection cassette. (J:101977)